drugset / Trial / NCT03275636

Haploidentical Donor vs mMUD in Hematological Malignancies

NCT03275636

Phase 2/3 Completed 98 enrolled DKMS
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this trial is to compare the outcome after partially matched (single mismatch) unrelated donor transplantation with haploidentical transplantation in a randomized controlled setting.

Timeline

Start
2018-01-01
Primary completion
2024-04-13
Completion
2024-04-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Peripheral blood stem cells Cell therapy